Trial intelligence / Profile preview

Safety of GSK Hib Vaccine Co-administered with Chinese DTPw in Infants

NCT00158795Phase 4Completed

Sponsor
GSK
Start
Jan 2005
Primary completion
Jul 2005
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

A Phase 4 trial of haemophilus influenzae type b vaccine in Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jan 2005; status: completed.

02

Drugs

haemophilus influenzae type b vaccine
03

Conditions

Haemophilus influenzae type b infection (Hib)

Beyond the preview

Go deeper on NCT00158795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00158795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call